UNIVERSITY VENTURE FUND II IS FIRST MONEY IN NAVIGEN PHARMACEUTICALS SEED ROUND

October 4, 2018

The Sorenson Impact Center’s University Venture Fund—Impact Investing (UVF II) closed its first investment in a seed round into Salt Lake City-based Navigen, Inc. UVF II’s investment was highly catalytic, unlocking over $1.5 million additional investment capital into the pharmaceutical company. Navigen, Inc. is an early stage drug discovery and development company that has developed […]